Sciencast Management’s QuidelOrtho QDEL Stock Holding History

Sciencast Management’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-8,397	Closed	-$613K	–	401
2023 Q3	$613K	Buy	8,397 +5,783	+221%	+$462K	0.28%	141
2023 Q2	$219K	Buy	+2,614	New	+$229K	0.18%	201
2021 Q2	–	Sell	-5,394	Closed	-$705K	–	658
2021 Q1	$705K	Buy	+5,394	New	+$996K	0.14%	222

Other funds holding QDEL

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

Sciencast Management's QDEL Position: Q4 2023 in Review

Sciencast Management sold out of QuidelOrtho (QDEL) in Q4 2023, closing a stake of 8,397 shares — an estimated $613K sold.

Sciencast Management first reported a position in QDEL in Q1 2021 and held it in 3 quarters. The position peaked at $705K in Q1 2021. 306 funds tracked by Wall St. Rank hold QDEL as of Q4 2023.

Sciencast Management reported no remaining QuidelOrtho position as of Q4 2023 after selling out during the quarter.
Sciencast Management sold 8,397 QuidelOrtho shares in Q4 2023, an estimated $613K.
Sciencast Management first reported a position in QuidelOrtho in Q1 2021 and held it in 3 quarters.
Sciencast Management's QuidelOrtho position peaked at $705K in Q1 2021.
306 funds tracked by Wall St. Rank held QuidelOrtho as of Q4 2023.

Based on Sciencast Management's 13F filing for Q4 2023, filed 14 Feb 2024.